Acrivon Therapeutics, Inc. ACRV
NASDAQ · United States · Health Technology
$2.07+0.02 (+0.98%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.43 | -0.50 | +14.4% | $0 | — | +6.9%$1.73→$1.85 |
| Q1 2026 | 2026-05-13 | -0.49 | -0.52 | +5.8% | — | — | +1.6%$1.89→$1.92 |
| Q4 2025 | 2026-03-19 | -0.49 | -0.46 | -6.5% | — | — | +1.2%$1.64→$1.66 |
| Q3 2025 | 2025-11-13 | -0.47 | -0.58 | +19.0% | — | — | -1.8%$2.28→$2.24 |
| Q2 2025 | 2025-08-13 | -0.55 | -0.59 | +6.8% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.51 | -0.65 | +21.5% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.54 | -0.70 | +22.9% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.59 | -0.59 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.